Abstract
Recommended thresholds for statin treatment to prevent cardiovascular (CV) events have encouraged wider access since the drugs were first introduced in the late 1980s. The National Institute for Health and Care Excellence (NICE) first recommended primary prevention with statins in those without pre-existing cardiovascular disease (CVD) in 2006, with the risk threshold lowered to 10% […]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
